IVVD
Price:
$0.814
Market Cap:
$97.23M
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. T...[Read more]
Industry
Biotechnology
IPO Date
2021-08-06
Stock Exchange
NASDAQ
Ticker
IVVD
According to Invivyd, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.45. This represents a change of -71.13% compared to the average of -1.56 of the last 4 quarters.
The mean historical PE Ratio of Invivyd, Inc. over the last ten years is -10.46. The current -0.45 PE Ratio has changed 330.02% with respect to the historical average. Over the past ten years (40 quarters), IVVD's PE Ratio was at its highest in in the December 2020 quarter at -0.46. The PE Ratio was at its lowest in in the June 2020 quarter at -1132.05.
Average
-10.46
Median
-2.80
Minimum
-35.56
Maximum
-0.69
Discovering the peaks and valleys of Invivyd, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 213.82%
Maximum Annual PE Ratio = -0.69
Minimum Annual Increase = -90.35%
Minimum Annual PE Ratio = -35.56
Year | PE Ratio | Change |
---|---|---|
2023 | -2.17 | 213.82% |
2022 | -0.69 | -79.83% |
2021 | -3.43 | -90.35% |
The current PE Ratio of Invivyd, Inc. (IVVD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.10
5-year avg
-10.46
10-year avg
-10.46
Invivyd, Inc.’s PE Ratio is less than Exscientia plc (0), greater than Recursion Pharmaceuticals, Inc. (-3.65), greater than Atea Pharmaceuticals, Inc. (-3.82), greater than Unity Biotechnology, Inc. (-1.72), greater than Icosavax, Inc. (-0.79), greater than REGENXBIO Inc. (-8.27), greater than Anebulo Pharmaceuticals, Inc. (-2.41), greater than Abeona Therapeutics Inc. (-4.99), greater than Black Diamond Therapeutics, Inc. (-4.22), greater than Generation Bio Co. (-3.70), greater than Kronos Bio, Inc. (-0.92), greater than Erasca, Inc. (-0.58), greater than C4 Therapeutics, Inc. (-3.94), greater than Edgewise Therapeutics, Inc. (-3.44), greater than Passage Bio, Inc. (-14.14), greater than Magenta Therapeutics, Inc. (-0.57), less than TRACON Pharmaceuticals, Inc. (-0.04), less than Aptevo Therapeutics Inc. (0.03), less than null (-0.05),
Company | PE Ratio | Market cap |
---|---|---|
0 | $622.39M | |
-3.65 | $1.63B | |
-3.82 | $303.92M | |
-1.72 | $24.43M | |
-0.79 | $769.04M | |
-8.27 | $567.38M | |
-2.41 | $46.68M | |
-4.99 | $240.39M | |
-4.22 | $305.13M | |
-3.70 | $145.50M | |
-0.92 | $59.36M | |
-0.58 | $807.96M | |
-3.94 | $374.42M | |
-3.44 | $1.64B | |
-14.14 | $43.48M | |
-0.57 | $42.44M | |
-0.04 | $194.57K | |
0.03 | $3.11M | |
-0.05 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Invivyd, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Invivyd, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Invivyd, Inc.'s PE Ratio?
How is the PE Ratio calculated for Invivyd, Inc. (IVVD)?
What is the highest PE Ratio for Invivyd, Inc. (IVVD)?
What is the 3-year average PE Ratio for Invivyd, Inc. (IVVD)?
What is the 5-year average PE Ratio for Invivyd, Inc. (IVVD)?
How does the current PE Ratio for Invivyd, Inc. (IVVD) compare to its historical average?